Page 147 - 南京医科大学自然版

第46卷第5期 杨浚沫，曾奕淙，周 何. 循环肿瘤DNA联合系统性炎症指标预测结直肠癌术后复发的研究进展［J］.
2026年5月 南京医科大学学报（自然科学版），2026，46（5）：762-770 ·769 ·

ing in colorectal cancer［J］. Mol Cancer，2022，21（1）：86 Lengthening and shortening of plasma DNA in hepatocel⁃
［14］O’SULLIVAN N J，TEMPERLEY H C，KYLE E T，et al. lular carcinoma patients［J］. Proc Natl Acad Sci USA，
Assessing circulating tumour DNA（ctDNA）as a prognos⁃ 2015，112（11）：E1317-E1325
tic biomarker in locally advanced rectal cancer：a system⁃ ［26］WAN J C M，MASSIE C，GARCIA⁃CORBACHO J，et al.
atic review and meta ⁃ analysis［J］. Int J Colorectal Dis， Liquid biopsies come of age：towards implementation of
2024，39（1）：82 circulating tumour DNA［J］. Nat Rev Cancer，2017，17
［15］YAMAMOTO T，KAWADA K，OBAMA K. Inflammation⁃ （4）：223-238
related biomarkers for the prediction of prognosis in ［27］CHAUDHURI A A，CHABON J J，LOVEJOY A F，et al.
colorectal cancer patients［J］. Int J Mol Sci，2021，22 Early detection of molecular residual disease in localized
（15）：8002 lung cancer by circulating tumor DNA profiling［J］. Can⁃
［16］KALIL J A，KRZYWON L，PETRILLO S K，et al. Feasi⁃ cer Discov，2017，7（12）：1394-1403
bility of ctDNA in detecting minimal residual disease and ［28］SIVARAMAKRISHNAN G，SRIDHARAN K，ALMU⁃
predicting recurrence for colorectal cancer liver metasta⁃ HARRAQI M A. DNA methylation⁃based machine learn⁃
ses［J］. Front Oncol，2024，14：1418696 ing models for classification of oral cancer and potentially
［17］LI Q G，XIAO Y W，HAN L Y，et al. Microbiome dysbio⁃ malignant lesions：a proof⁃of⁃concept study［J］. J Stomatol
sis，neutrophil recruitment and mesenchymal transition of Oral Maxillofac Surg，2026，127（2）：102594
mesothelial cells promotes peritoneal metastasis of ［29］KASI P M，SAWYER S，GUILFORD J，et al. BESPOKE
colorectal cancer［J］. Nat Cancer，2025，6（3）：493-510 study protocol：a multicentre，prospective observational
［18］WANG Y M，WANG Z，WANG C Q，et al. Nonsense⁃me⁃ study to evaluate the impact of circulating tumour DNA
diated mRNA decay inhibits TRAF6⁃dependent anti⁃tu⁃ guided therapy on patients with colorectal cancer［J］.
mor immunity in colorectal cancer［J］. Cell Rep Med， BMJ Open，2021，11（9）：e047831
2025，6（12）：102463 ［30］GOLDBERG S B，NARAYAN A，KOLE A J，et al. Early
［19］HU M Y，XU Y，WANG Y Q，et al. Gut microbial⁃derived assessment of lung cancer immunotherapy response via
N⁃acetylmuramic acid alleviates colorectal cancer via the circulating tumor DNA［J］. Clin Cancer Res，2018，24
AKT1 pathway［J］. Gut，2025，74（8）：1230-1245 （8）：1872-1880
［20］CHOI H，HWANG W. Anesthetic approaches and their ［31］DA SILVA T F，DE AZEVEDO J C JR，TEIXEIRA E B，
impact on cancer recurrence and metastasis：a comprehen⁃ et al. From haystack to high precision：advanced sequenc⁃
sive review［J］. Cancers，2024，16（24）：4269 ing methods to unraveling circulating tumor DNA muta⁃
［21］COOLS⁃LARTIGUE J，SPICER J，MCDONALD B，et al. tions［J］. Front Mol Biosci，2024，11：1423470
Neutrophil extracellular traps sequester circulating tumor ［32］KRAMER A，GREUTER M J E，SCHRAA S J，et al. Ear⁃
cells and promote metastasis［J］. J Clin Invest，2013，123 ly evaluation of the effectiveness and cost⁃effectiveness of
（8）：3446-3458 ctDNA ⁃ guided selection for adjuvant chemotherapy in
［22］王 娜，梁 芳，陈 彬. 中性粒细胞胞外陷阱在肿瘤 stage Ⅱ colon cancer［J］. Ther Adv Med Oncol，2024，
中的研究进展［J］. 医学新知，2025，35（9）：1091-1098 16：17588359241266164
WANG N，LIANG F，CHEN B. Research progress of neu⁃ ［33］ZHANG Y Y，LIU X，XU M F，et al. Prognostic value of
trophil extracellular traps in tumors［J］. New Medicine， pretreatment systemic inflammatory markers in patients
2025，35（9）：1091-1099 with locally advanced rectal cancer following neoadjuvant
［23］许 东，谢逸林，路慧欣，等. Ⅲc期结直肠癌根治术后 chemoradiotherapy［J］. Sci Rep，2020，10（1）：8017
复发转移的危险因素分析［J］. 中国实用外科杂志， ［34］朱吉玥，张 波，李亚茹，等. 全身炎症反应指数对早期
2025，45（2）：202-207 结直肠癌内镜黏膜下剥离术后非治愈性切除的预测价
XU D，XIE Y L，LU H X，et al. Analysis of risk factors for 值［J］. 实用医学杂志，2025，41（5）：716-723
recurrence and metastasis after radical surgery for stage ZHU J Y，ZHANG B，LI Y R，et al. The predictive value
Ⅲ c colorectal cancer［J］. Chinese Journal of Practical of the systemic inflammation response index for non⁃cura⁃
Surgery，2025，45（2）：202-207 tive resection after endoscopicsubmucosal dissection for
［24］MO S B，YE L，WANG D Y，et al. Early detection of mo⁃ early colorectal cancer［J］. The Journal of Practical Medi⁃
lecular residual disease and risk stratification for stage Ⅰ cine，2025，41（5）：716-723
to Ⅲ colorectal cancer via circulating tumor DNA methyl⁃ ［35］SHEN X，XIANG M Y，TANG J D，et al. Evaluation of pe⁃
ation［J］. JAMA Oncol，2023，9（6）：770-778 ripheral blood inflammation indexes as prognostic mark⁃
［25］JIANG P Y，CHAN C W，ALLEN CHAN K C，et al. ers for colorectal cancer metastasis［J］. Sci Rep，2024，14